Global Cancer Gene Therapy Market Set for Remarkable Growth, Forecast to Reach USD 5.3 Billion by 2032

The global cancer gene therapy market is on the brink of substantial expansion, with projections indicating a robust compound annual growth rate (CAGR) of 10.1% from 2022 to 2032. According to a recent report by Future Market Insights (FMI), the market, which was valued at USD 2 billion in 2022, is expected to skyrocket to …

Global Cancer Gene Therapy Market Expected to Grow at 10.1% CAGR, Reaching USD 5.3 Billion by 2032

The global cancer gene therapy market is poised for significant growth, projected to surge at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2032. According to Future Market Insights (FMI), the industry, valued at USD 2 billion in 2022, is anticipated to reach a staggering USD 5.3 billion by 2032. One of …

Cancer Gene Therapy Market Aims for a Staggering US$ 5.3 Billion Valuation in 2032 | Future Market Insights,Inc.

From 2022 to 2032, the global cancer gene therapy market is anticipated to expand at a 10.1% compound annual growth rate (CAGR) and reach US$ 2 billion in 2022. The oncolytic virotherapy segment held 49.3% of the global cancer gene therapy market in 2021, according to Future Market Insights (FMI). This market is projected to …

Revolutionizing Healthcare | The Surging Demand for Cancer Gene Therapy

According to Future Market Insights’ most recent revised industry report, the Global Cancer Gene Therapy Market Demand will grow at a 10.1% CAGR over the forecast period, reaching US$ 5.3 Billion in 2032. Gene therapy is a branch of medicine that seeks to cure or significantly enhance the treatment of diseases for whom there are …